000 01511 a2200457 4500
005 20250514233810.0
264 0 _c20060310
008 200603s 0 0 eng d
022 _a0959-4973
024 7 _a10.1097/01.cad.0000172834.78068.7c
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aParanjpe, Pankaj V
245 0 0 _aTumor-targeted and activated bioconjugates for improved camptothecin delivery.
_h[electronic resource]
260 _bAnti-cancer drugs
_cAug 2005
300 _a763-75 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmino Acids
_xchemistry
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aCathepsin B
_xchemistry
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug Stability
650 0 4 _aEsters
650 0 4 _aFemale
650 0 4 _aFolic Acid
_xchemistry
650 0 4 _aHumans
650 0 4 _aHydrolysis
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Conformation
650 0 4 _aNeoplasm Transplantation
650 0 4 _aPolyethylene Glycols
_xchemistry
650 0 4 _aRats
650 0 4 _aRats, Inbred F344
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aStein, Stanley
700 1 _aSinko, Patrick J
773 0 _tAnti-cancer drugs
_gvol. 16
_gno. 7
_gp. 763-75
856 4 0 _uhttps://doi.org/10.1097/01.cad.0000172834.78068.7c
_zAvailable from publisher's website
999 _c15682496
_d15682496